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LETTER
A novel use of arterial spin
labelling MRI to demonstrate
focal hypoperfusion in
individuals with posterior
cortical atrophy: a multimodal
imaging study
INTRODUCTION
Posterior cortical atrophy (PCA) is a rare
neurodegenerative syndrome, typically
due to Alzheimer pathology, characterised
by impairments in higher-order visual
function and other parieto-occipital
skills.1 MRI measures of atrophy and
18F-labelled ﬂuorodeoxyglucose (FDG)
positron emission tomography (PET) mea-
sures of glucose metabolism typically
show posterior cortical deﬁcits broadly
mirroring the focal cognitive deﬁcits.1 By
contrast, amyloid PET studies demonstrate
that ﬁbrillar amyloid is widely deposited
across the cortex.2 Arterial spin labelling
(ASL) is an MRI methodology that uses
endogenous arterial blood water as a
tracer to quantify cerebral blood ﬂow
(CBF).3 We aimed to assess the ability of
ASL to detect patterns of reduced CBF in
PCA, and to compare these results with
those from other imaging modalities.
METHODS
Five patients fulﬁlling clinical diagnostic
criteria for PCA,4 and ﬁve controls
attended for three scanning visits usually
on consecutive days. On day 1, MRI scans
were acquired on a 3 T Siemens TIM Trio
scanner with a 32-channel phased array
head-coil. Sequences included a sagittal
three-dimensional (3D) MPRAGE T1-
weighted volumetric scan (acquisition
time 9 min 23 s, TE/TR/TI=2.9/2200/
900 ms, dimensions 256×256×208,
voxel size 1.1×1.1×1.1 mm), and coronal
T2 ﬂuid-attenuated inversion recovery
(TE/TR/TI=87/9000/2500 ms, voxel size
0.9375×0.9375×5 mm). Perfusion data
were acquired using pulsed ASL (FAIR
Q2TIPS) with an 8-segment, background-
suppressed 3D GRASE imaging readout5
(acquisition time 6 min 40 s, TI1/2=800/
2000 ms, voxel size 3.8×3.8×4.0 mm,
refocusing pulse ﬂip angle 130°, ﬁve repe-
titions). A set of three saturation recovery
images (TR=1,2,5 s) with the same
readout module was also acquired to gen-
erate tissue M0 and T1 maps for CBF
quantiﬁcation. On day 2, each participant
underwent a 10 min PET scan 50 min
after an intravenous bolus of 300 MBq
18F-ﬂorbetapir. On day 3, a 20 min PET
scan was acquired 30–35 min postinjec-
tion of 185 MBq 18F-FDG. PET scans
were performed on a GE Discovery ST
PET/CT scanner, with CT scans acquired
immediately before each scan for attenu-
ation correction.
T1-weighted images were processed
using a Gaussian mixture model optimised
through expectation maximisation to
produce probabilistic segmentations of
grey matter, white matter and cerebro-
spinal ﬂuid. Regional labels were pro-
duced simultaneously from the integration
of the template parcellations and the seg-
mentation6 to deﬁne (1) a reference
Figure 1 Single-participant axial images for one control participant and ﬁve patients with PCA showing cerebral blood ﬂow (ASL), glucose
metabolism (FDG-PET), atrophy (structural MRI), and amyloid deposition (ﬂorbetapir-PET). For clinical purposes, 18F-ﬂorbetapir images should be
read on a grey scale. ASL, arterial spin labelling; CBF, cerebral blood ﬂow; FDG-PET,18 F-labelled ﬂuorodeoxyglucose positron emission tomography;
PCA, posterior cortical atrophy; SUVR, standard uptake value ratio.
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region (whole cerebellum) for the PET
normalisation; and (2) frontal, medial
temporal, lateral temporal, parietal, pos-
terior cingulate and occipital grey matter
lobar regions which were subsequently
corrected for total intracranial volume.
ASL images were aligned to the
T1-weighted image using a symmetric
afﬁne registration algorithm to reduce the
effects of any residual motion.7 CBF maps
were generated by ﬁtting a derivative of
the general kinetic model to the ASL
data.8 Florbetapir scans were rated
amyloid-positive/negative on grey-scaled
images according to standard guidelines;
FDG scans were rated for regional hypo-
metabolism. Standard uptake value ratios
were calculated for each grey matter lobar
region and as a composite, using whole
cerebellum as the reference region.
Neuroimaging data from each patient
were compared against the controls using
a modiﬁed t test developed to conduct
single participant comparisons, by treating
the control sample as sample statistics
rather than as population parameters.9 To
explore the regional relationships between
the different techniques, z-scores for each
modality and each lobe were calculated
relative to controls, and linear regression
was used across all brain regions to
compare imaging modalities.
RESULTS
Participant demographics and neuroimaging
data are shown in online supplementary
table S1. At the time of scanning, the
patients (3 female, 2 male) had a mean±SD
age of 59.4±1.8 years. Single-participant
images are shown in the ﬁgure 1, alongside
the results from a control participant (male,
59 years old) as a reference. All patients
were amyloid-positive, with ﬁbrillar
amyloid distributed widely across the
cortex. Much more focal, posterior cortical
reductions in cerebral blood ﬂow, glucose
metabolism and atrophy were seen. While
atrophy in posterior regions was present in
all patients, on visual assessment it was less
pronounced than the metabolic deﬁcits
assessed using either FDG-PETor ASL.
Quantiﬁcation of the regional results for
each modality is shown in the online sup-
plementary table S1. Compared with con-
trols, there were consistent and signiﬁcant
reductions in grey matter volume and
glucose metabolism in the parietal lobe in
all patients, and in the parietal, occipital
and lateral temporal lobes in the majority.
Cerebral blood ﬂow reductions were seen
in the parietal and occipital lobes and pos-
terior cingulate for all patients, reaching
signiﬁcance in three. In all cases amyloid
deposition was distributed widely across
the cortex, including the frontal lobes.
Regression analyses showed no signiﬁcant
relationships between amyloid load and
any other biomarker. There was no evi-
dence for a relationship between grey
matter volume and CBF (p=0.4), border-
line evidence for a relationship between
grey matter volume and FDG-PET metab-
olism (p=0.05), but a signiﬁcant correl-
ation between regional CBF and FDG-PET
metabolism (p=0.004, R2=0.26).
DISCUSSION
All individuals in this study had clinical
and cognitive phenotypes consistent with
PCA, and unequivocally positive ﬂorbeta-
pir PET scans consistent with underlying
AD pathology. In keeping with previous
studies, amyloid deposition was widely dis-
tributed across the cortex2 while atrophy,
hypometabolism and CBF deﬁcits were all
more marked in posterior cortical regions.
Previous studies have shown corres-
pondence between the pattern of cerebral
hypometabolism measured using
FDG-PET and ASL measures of CBF in
typical late-onset AD10 and semantic
dementia.11 Here, we extend these ﬁnd-
ings to PCA, but importantly show that
these group level changes extend to indi-
vidual patients. Posterior cortical CBF
reduction was detectable in each of the
individual patients with PCA and broadly
mirrored by the observed focal patterns of
FDG-PET glucose hypometabolism—the
gold standard for detecting regional meta-
bolic changes. Both modalities exhibited
more extensive changes than expected
purely due to the posterior atrophy seen
on structural imaging. These data show
that ASL, a non-invasive MR sequence
which can implemented on standard clin-
ical 3 T MR scanners, can usefully dem-
onstrate CBF changes in individual
patients with PCA. ASL may be a useful
diagnostic adjunct in suspected PCA—and
potentially other focal dementias—where
an FDG-PET scan is unavailable.
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